Promoter methylation of p16, DAPK, CDH1, and TIMP-3 genes in cervical cancer: Correlation with clinicopathologic characteristics

International Journal of Gynecological Cancer

Volumn 16, Issue 3, 2006, Pages 1234-1240

  Jeong, D H ^a   Youm, M Y ^a   Kim, Y N ^a   Lee, K B ^a   Sung, M S ^a   Yoon, H K ^a   Kim, K T ^a  

^a Inje University College of Medicine   (South Korea)

Author keywords

Cervical cancer; Methylation; Promoter

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE; PROTEIN P16; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CELL ADHESION; CELL CYCLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EVALUATION; FEMALE; GENE FREQUENCY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEDICAL RECORD; METHYLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA;

ADULT; AGE FACTORS; AGED; APOPTOSIS REGULATORY PROTEINS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CARCINOMA; CERVIX UTERI; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; PROMOTER REGIONS (GENETICS); PROMOTER REGIONS, GENETIC; TISSUE INHIBITOR OF METALLOPROTEINASE-3; UTERINE CERVICAL NEOPLASMS;

EID: 33745109881     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00522.x     Document Type: Article

References (40)

1. NIH. Cervical cancer. NIH Consens Statement 1996 14: 1 38.
2. Pisani P Parkin DM Bray F Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999 83: 18 29.
3. Walboomers JM Jacobs MV Manos MM et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999 189: 12 9.
4. Schiffman MH Castle P. Epidemiologic studies of a necessary causal risk factor: human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst 2003 95: E2.
5. Bosch FX Manos MM Munoz N et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) study group. J Natl Cancer Inst 1995 87: 796 802.
6. Waggoner SE. Cervical cancer. Lancet 2003 361: 2217 25.
7. Holowaty P Miller AB Rohan T To T. Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst 1999 91: 252 8.
8. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002 16: 6 21.
9. Russo VEA Martienssen RA Riggs AD, eds. Epigenetic mechanisms of gene regulation. Plainview, NY: Cold Spring Harbor Laboratory Press, 1996.
10. Yoder JA Walsh CP Bestor TH. Cytosine methylation and the ecology of intragenomic parasites. Trends Genet 1997 13: 335 40.
11. Baylin SB Herman JG Graff JR Vertino PM Issa JP. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 1998 72: 141 96.
12. Bird AP. CpG-rich islands and the function of DNA methylation. Nature 1986 321: 209 13.
13. Gardiner-Garden M Frommer M. CpG islands in vertebrate genomes. J Mol Biol 1987 196: 261 82.
14. Li LC Okino ST Dahiya R. DNA methylation in prostate cancer. Biochim Biophys Acta 2004 1704: 87 102.
15. Herman JG Baylin SB. Gene silencing in cancer in association with promoter methylation. N Engl J Med 2003 349: 2042 54.
16. Jones PA Laird PW. Cancer epigenetic comes of age. Nat Genet 1999 21: 163 7.
17. Esteller M Corn PG Baylin SB Herman JG. A gene methylation profile of human cancer. Cancer Res 2001 61: 3225 9.
18. Yang HJ Liu VW Wang Y et al. Detection of hypermethylated genes in tumor and plasma of cervical cancer patients. Gynecol Oncol 2004 93: 435 40.
19. Dong SM Kim HS Rha SH Sidransky D. Promoter methylation of multiple genes in carcinoma of the uterine cervix. Clin Cancer Res 2001 7: 1982 6.
20. Virmani AK Muller C Rathi A Zoechbauer-Mueller S Mathis M Gazdar AF. Aberrant methylation during cervical carcinogenesis. Clin Cancer Res 2001 7: 584 9.
21. Narayan G Arias-Pulido H Koul S et al. Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome. Mol Cancer 2003 2: 24.
22. Widschwendter A Gattringer C Ivarsson L et al. Analysis of aberrant DNA methylation and human papillomavirus DNA in cervicovaginal specimens to detect invasive cervical cancer and its precursors. Clin Cancer Res 2004 10: 3396 400.
23. Lea JS Coleman R Kurien A et al. Aberrant p16 methylation is a biomarker for tobacco exposure in cervical squamous cell carcinogenesis. Am J Obstet Gynecol 2004 190: 674 9.
24. Wong YF Chung TK Cheung TH et al. Methylation of p16INK4A in primary gynecologic malignancy. Cancer Lett 1999 136: 231 5.
25. Widschwendter A Muller HM Fiegl H et al. DNA methylation in serum and tumors of cervical cancer patients. Clin Cancer Res 2004 10: 565 71.
26. Ivanova T Vinokurova S Petrenko A et al. Frequent methylation of 5′ flanking region of TIMP-2 gene in cervical cancer. Int J Cancer 2004 108: 882 6.
27. Widschwendter A Ivarsson L Blassnig A et al. CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patients. Int J Cancer 2004 109: 163 6.
28. Herman JG Graff JR Myohanen S Nelkin BD Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996 93: 9821 6.
29. Esteller M Sanchez-Cespedes M Rosell R Sidransky D Baylin SB Herman JG. Detection of aberrant promoter methylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res 1999 59: 67 70.
30. Bachman KE Herman JG Corn PG et al. Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggests a suppressor role in kidney, brain, and other human cancers. Cancer Res 1999 59: 798 802.
31. Sherr CJ. G1 phase progression: cycling on cue. Cell 1994 79: 551 5.
32. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995 81: 323 30.
33. Deiss LP Feinstein E Berissi H Cohen O Kimchi A. Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death. Genes Dev 1995 9: 15 30.
34. Inbal B Cohen O Polak-Charcon S et al. DAP kinase links the control of apoptosis to metastasis. Nature 1997 390: 180 4.
35. Simpson DJ Clayton RN Farrell WE. Preferential loss of death associated protein kinase expression in invasive pituitary tumours is associated with either CpG island methylation or homozygous deletion. Oncogene 2002 21: 1217 24.
36. Christofori G. Changing neighbours, changing behaviour: cell adhesion molecule-mediated signaling during tumor progression. EMBO J 2003 22: 2318 23.
37. Chambers AF Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997 89: 1260 70.
38. Kang S Kim JW Kang GH et al. Polymorphism in folate- and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer. Gynecol Oncol 2005 96: 173 80.
39. Lombaerts M Middeldorp JW van der Weide E et al. Infiltrating leukocytes confound the detection of E-cadherin promoter methylation in tumors. Biochem Biophys Res Commun 2004 319: 697 704.
40. Hoskins WJ Perez CA Young RC. Principles and practice of gynecologic oncology. Philadelphia, PA: Lippincott Raven Publishers, 1997.